NVO · Novo Nordisk A/S

Summary

Novo Nordisk reports repurchasing 11,007,992 B shares for DKK 2.84 billion under its DKK 3.8 billion share buyback program initiated February 4, 2026.

Key takeaways

• Initiated DKK 3.8 billion B share repurchase program on February 4, 2026, ending May 4, 2026.
• Total repurchases since inception: 11,007,992 B shares for DKK 2,835,176,799 at average price DKK 257.56.
• Recent transactions April 7-10: 1,040,000 B shares for DKK 248,772,251.
• Holds 28,397,791 B shares as treasury (0.6% of share capital).
• Part of DKK 15 billion 12-month buyback program starting February 4, 2026.